Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cate Speake

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Biomarker Insights|October 14, 2015
Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay ValidationCate Speake, Jared M Odegard
Plos One|September 24, 2015
The Relationship of Immune Cell Signatures to Patient Survival Varies within and between Tumor TypesPeter S Linsley, Damien Chaussabel, Cate Speake
Genome Biology|May 14, 2009
Malaria sporozoite proteome leaves a trailMarissa Vignali, Cate Speake, Patrick E Duffy
Immunology and Cell Biology|January 23, 2021
The many faces of islet antigen-specific CD8 T cells: clues to clinical outcome in type 1 diabetesAlice E Wiedeman, Cate Speake, Sarah Alice Long
Inflammatory Bowel Diseases|August 25, 2025
ScreeningLessons from Prediction and Prevention of Type 1 DiabetesCate Speake, Adam Lacy-Hulbert, James Lord, et al.
Plos One|October 15, 2014
Copy number loss of the interferon gene cluster in melanomas is linked to reduced T cell infiltrate and poor patient prognosisPeter S Linsley, Cate Speake, Elizabeth Whalen, et al.
Current Opinion in Gastroenterology|July 5, 2024
Immune markers of severe acute pancreatitisPeter J Lee, Georgios I Papachristou, Cate Speake, et al.
JCI Insight|March 5, 2019
Cell type-specific immune phenotypes predict loss of insulin secretion in new-onset type 1 diabetesMatthew J Dufort, Carla J Greenbaum, Cate Speake, et al.
Diabetes Care|February 6, 2020
Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody-Positive IndividualsMichelle So, Colin O'Rourke, Henry T Bahnson, et al.
JCI Insight|March 5, 2019
B lymphocyte alterations accompany abatacept resistance in new-onset type 1 diabetesPeter S Linsley, Carla J Greenbaum, Cate Speake, et al.
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Biomarker Insights|October 14, 2015
Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay ValidationCate Speake, Jared M Odegard
Plos One|September 24, 2015
The Relationship of Immune Cell Signatures to Patient Survival Varies within and between Tumor TypesPeter S Linsley, Damien Chaussabel, Cate Speake
Genome Biology|May 14, 2009
Malaria sporozoite proteome leaves a trailMarissa Vignali, Cate Speake, Patrick E Duffy
Immunology and Cell Biology|January 23, 2021
The many faces of islet antigen-specific CD8 T cells: clues to clinical outcome in type 1 diabetesAlice E Wiedeman, Cate Speake, Sarah Alice Long
Inflammatory Bowel Diseases|August 25, 2025
ScreeningLessons from Prediction and Prevention of Type 1 DiabetesCate Speake, Adam Lacy-Hulbert, James Lord, et al.
Plos One|October 15, 2014
Copy number loss of the interferon gene cluster in melanomas is linked to reduced T cell infiltrate and poor patient prognosisPeter S Linsley, Cate Speake, Elizabeth Whalen, et al.
Current Opinion in Gastroenterology|July 5, 2024
Immune markers of severe acute pancreatitisPeter J Lee, Georgios I Papachristou, Cate Speake, et al.
JCI Insight|March 5, 2019
Cell type-specific immune phenotypes predict loss of insulin secretion in new-onset type 1 diabetesMatthew J Dufort, Carla J Greenbaum, Cate Speake, et al.
Diabetes Care|February 6, 2020
Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody-Positive IndividualsMichelle So, Colin O'Rourke, Henry T Bahnson, et al.
JCI Insight|March 5, 2019
B lymphocyte alterations accompany abatacept resistance in new-onset type 1 diabetesPeter S Linsley, Carla J Greenbaum, Cate Speake, et al.
Pageof 12